Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025.
- Largest single sale: $1.6M (60,850 shares) of Caris Life Sciences, Inc. on Dec 11, 2025. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Caris Life Sciences, Inc. (CAI) | Senior Vice President, Chief Financial Officer, and Chief Accounting Officer | Jun 17, 2025 | May 18, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 15, 2026, Caris Life Sciences, Inc.: 9,771 shares withheld by the company for taxes. 1 filing: 1
- Mar 6, 2026, Caris Life Sciences, Inc.: 63,971 shares granted. 1 filing: 1
- Dec 11, 2025, Caris Life Sciences, Inc.: sold 62,250 shares for $1.7M, under a disclosed plan; 62,250 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.